Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

NMI®, a global leader in embedded payments infrastructure, announces NMI Customer Token Vault, a new extension to the NMI Gateway. Customer Token Vault introduces network tokenization with dynamic ...

Innovative synthetic biology techniques are revolutionizing microbiota-based therapies, enhancing microbial functions for improved health and disease treatment.

Those in the placebo group will have the option to cross over to the therapy treatment at a 28-week time period ... The therapy launch in the US market is expected in 2027. Leveraging CRISPR/Cas9 ...

which could put additional pressure on Pfizer to find growth from its non-COVID treatments. Sustainabilitycategory McDonald's settles lawsuit challenging Latino scholarship program 11:02 AM UTC ...

Kennedy Jr. will di­vest his in­ter­ests in sev­er­al bio­phar­ma com­pa­nies, in­clud­ing CRISPR Ther­a­peu­tics and Drag­on­fly Ther­a­peu­tics, if con­firmed by the ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

A pioneering new treatment promises to tackle a wider range of cancers, with fewer side-effects than conventional radiotherapy. It also takes less than a second. In a series of vast underground ...

This partnership underscores a shared commitment to environmental sustainability and biodiversity conservation and was initiated when Aldar joined the Abu Dhabi Mangrove Initiative (ADMI) partnership ...

With Casgevy’s approval, CRISPR Therapeutics offers a new treatment option to an estimated 35,000 patients living with severe SCD or TDT across the United States and Europe, with additional ...